59.65
Disc Medicine Inc stock is traded at $59.65, with a volume of 214.79K.
It is down -0.03% in the last 24 hours and down -0.26% over the past month.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
See More
Previous Close:
$59.66
Open:
$59.85
24h Volume:
214.79K
Relative Volume:
0.60
Market Cap:
$2.07B
Revenue:
-
Net Income/Loss:
$-91.00M
P/E Ratio:
-16.25
EPS:
-3.67
Net Cash Flow:
$-74.38M
1W Performance:
-1.17%
1M Performance:
-0.26%
6M Performance:
+9.44%
1Y Performance:
+22.22%
Disc Medicine Inc Stock (IRON) Company Profile
Name
Disc Medicine Inc
Sector
Industry
Phone
(617) 674-9274
Address
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
IRON
Disc Medicine Inc
|
59.65 | 2.07B | 0 | -91.00M | -74.38M | -3.67 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-21-25 | Initiated | Truist | Buy |
Jul-03-25 | Resumed | Morgan Stanley | Overweight |
Jun-11-25 | Resumed | Raymond James | Strong Buy |
Feb-27-25 | Initiated | TD Cowen | Buy |
Nov-05-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Nov-04-24 | Upgrade | Raymond James | Outperform → Strong Buy |
Oct-23-24 | Initiated | Jefferies | Buy |
Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
Aug-22-24 | Initiated | Wells Fargo | Overweight |
Apr-01-24 | Downgrade | Raymond James | Strong Buy → Outperform |
Dec-19-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jun-09-23 | Upgrade | Raymond James | Outperform → Strong Buy |
Jun-07-23 | Initiated | H.C. Wainwright | Buy |
May-17-23 | Initiated | Raymond James | Outperform |
Apr-28-23 | Initiated | Cantor Fitzgerald | Overweight |
Apr-21-23 | Initiated | Stifel | Buy |
Apr-20-23 | Initiated | Morgan Stanley | Overweight |
Mar-23-23 | Initiated | BMO Capital Markets | Outperform |
Feb-28-23 | Initiated | SVB Securities | Outperform |
View All
Disc Medicine Inc Stock (IRON) Latest News
Chart based analysis of Disc Medicine Inc. trendsQuarterly Performance Summary & High Accuracy Swing Entry Alerts - Newser
Technical analysis overview for Disc Medicine Inc. stock2025 Top Decliners & Weekly High Potential Stock Alerts - Newser
Predicting Disc Medicine Inc. trend using moving averagesEarnings Risk Report & Free Real-Time Volume Trigger Notifications - Newser
Evaluating Disc Medicine Inc. with trendline analysis2025 Price Action Summary & AI Driven Price Predictions - Newser
Applying Elliott Wave Theory to Disc Medicine Inc.Quarterly Portfolio Summary & Community Consensus Trade Alerts - Newser
Will a bounce in Disc Medicine Inc. offer an exit2025 Market Overview & Risk Managed Investment Entry Signals - Newser
Disc Medicine Inc. stock retracement – recovery analysisWeekly Stock Report & Fast Gaining Stock Reports - Newser
Can volume confirm reversal in Disc Medicine Inc.Gap Up & Fast Entry Momentum Trade Alerts - Newser
Intraday pattern recognizer results for Disc Medicine Inc.Weekly Trading Summary & Weekly Setup with ROI Potential - Newser
Real time breakdown of Disc Medicine Inc. stock performanceJuly 2025 Final Week & Low Drawdown Trading Strategies - Newser
Is Disc Medicine Inc. in a long term uptrendJuly 2025 PostEarnings & Real-Time Stock Price Movement Reports - sundaytimes.kr
Order flow analysis tools used on Disc Medicine Inc.Market Risk Report & Low Volatility Stock Recommendations - Newser
Analyzing net buyer seller activity in Disc Medicine Inc.2025 Trade Ideas & Real-Time Volume Analysis Alerts - Newser
Ranking Disc Medicine Inc. among high performing stocks via toolsTrade Ideas & AI Powered Market Entry Ideas - Newser
Regression analysis insights on Disc Medicine Inc. performance2025 Volatility Report & Verified Entry Point Signals - Newser
Has Disc Medicine Inc. found a price floorTrade Analysis Report & Long-Term Safe Return Strategies - Newser
Using portfolio simulators with Disc Medicine Inc. includedMarket Activity Report & Low Risk Profit Maximizing Plans - Newser
Smart tools for monitoring Disc Medicine Inc.’s price actionEarnings Recap Summary & Fast Entry High Yield Tips - Newser
What moving averages say about Disc Medicine Inc.2025 Top Gainers & Safe Entry Momentum Tips - Newser
Automated trading signals detected on Disc Medicine Inc.Analyst Downgrade & Verified Momentum Stock Ideas - Newser
Is Disc Medicine Inc. stock influenced by commodity pricesJuly 2025 Market Mood & Low Risk Profit Maximizing Plans - sundaytimes.kr
What machine learning models say about Disc Medicine Inc.2025 Key Lessons & Expert Approved Momentum Trade Ideas - Newser
Is Disc Medicine Inc. stock entering bullish territory2025 Bull vs Bear & Expert-Curated Trade Recommendations - Newser
Analyzing drawdowns of Disc Medicine Inc. with statistical toolsWeekly Stock Report & Technical Confirmation Trade Alerts - Newser
Disc Medicine Inc Stock (IRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):